New mesh aims to stop hiatal hernias from coming back
NCT ID NCT07070115
First seen Jun 27, 2026 · Last updated Aug 19, 2026 · Updated 2 times
Summary
This study looks at how well a special mesh called OviTex works for fixing hiatal hernias. About 173 adults having robotic or laparoscopic hernia repair will be followed for 24 months to see if the hernia returns or if there are complications. The goal is to improve long-term outcomes for people with this condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 173 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Jul 2032
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
22 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patient is a candidate for an elective robotic or laparoscopic primary hiatal hernia repair with the use of OviTex Core Resorbable or OviTex 1S Resorbable. 2. Patient is willing and able to voluntarily sign the IRB-approved Informed Consent Form for the study. 3. Patient is at least 22 years old at the time of surgery. 4. Patient is not pregnant and not planning to become pregnant during the duration of the study (5 years). 5. Patient is able and willing to comply with the study requirements including completion of patient questionnaires and clinic evaluations. Exclusion Criteria (Baseline): 1. Patient has a Body Mass Index (BMI) of ≥ 35. 2. Patient meets the Centers for Disease Control (CDC) Surgical Site Infection (SSI) Wound Classification Class IV (Dirty-Infected) criteria. 3. Patient has a Type I hiatal hernia (defined as only the esophagogastric junction is above the diaphragm). 4. Patient has a life expectancy of less than five years making it unlikely that the subject will successfully achieve five-year follow-up. 5. Patient is a current nicotine user (including smokeless, vaporized, etc.) 6. Patient has a history of illicit drug or alcohol abuse (in the last three years). 7. Patient has an allergy to ovine-derived products or a known sensitivity to polyglycolic acid (PGA). 8. Patient has an allergy to barium. 9. Patient's surgery will include the use of an anti-reflux implantable device (LINX, etc.). 10. Patient's surgery requires the use of an additional mesh device or a pledget for reinforcement. 11. Patient has participated in another gastrointestinal (GI) clinical study within the past 30 days or is currently involved in another clinical study excluding observational and registry studies. 12. Patient had previous surgery at the gastroesophageal junction. 13. Patient had a prior hiatal hernia repair. 14. Patient has an incarcerated hernia that requires emergent intervention. 15. Patient is a prisoner. Exclusion Criteria (Intra-operative): 1. Patient is unable to receive OviTex Core Resorbable or OviTex 1S Resorbable at time of surgery. 2. Surgery requires the use of an additional mesh device or a pledget for reinforcement. 3. Surgery includes the use of an anti-reflux implantable device (LINX, etc.). 4. Surgery performed as an open procedure. 5. Patient has a condition, which in the Investigator's opinion, may put the patient at increased risk, confound study data, or interfere significantly with the patient's participation in the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Hiatal hernia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
5 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
SurgOne, PC
RECRUITINGDenver, Colorado, 80210, United States
-
The University of Texas at Austin - Dell Medical School
RECRUITINGAustin, Texas, 78712, United States
-
University of Kentucky
RECRUITINGLexington, Kentucky, 40536, United States
-
University of South Alabama Health
RECRUITINGMobile, Alabama, 36617, United States
-
Wake Forest University Health Sciences
RECRUITINGCharlotte, North Carolina, 28204, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Pre-Surgery checklist predict who will still have reflux after fundoplication?
- Can a less invasive reflux surgery match the standard one?
- Can surgery offer lasting relief for chronic heartburn? a large registry investigates
- Unnecessary test? study questions routine throat tube before reflux surgery
- Single-Port robot takes on complex belly surgeries
- Keyhole surgery offers relief for hidden hiatal hernia sufferers